Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
Siddharth Sridhar, Vincent C.C. Cheng, Shuk-Ching Wong, Cyril C.Y. Yip, Shusheng Wu, Anthony W.I. Lo, Kit-Hang Leung, Winger W.N. Mak, Jianpiao Cai, Xin Li, Jasper F.W. Chan, Susanna K.P. Lau, Patrick C.Y. Woo, Wai-Ming Lai, Tze-Hoi Kwan, Timmy W.K. Au, Chung-Mau Lo, Sally C.Y. Wong, and Kwok-Yung Yuen
Author affiliations: The University of Hong Kong, Hong Kong, China (S. Sridhar, V.C.C. Cheng, S.-C. Wong, C.C.Y. Yip, S. Wu, K.-H. Leung, W.W.N. Mak, J. Cai, X. Li, J.F.W. Chan, S.K.P. Lau, P.C.Y. Woo, C.-M. Lo, S.C.Y. Wong, K.-Y. Yuen); Queen Mary Hospital, Hong Kong (A.W.I. Lo, T.W.K. Au); Princess Margaret Hospital, Hong Kong (W.-M. Lai); Tuen Mun Hospital, Hong Kong (T.-H. Kwan)
Main Article
Figure 1
Figure 1. Phylogenetic analyses of the partial RNA-dependent RNA polymerase region of HEV strains involved in study of donor-derived genotype 4 HEV infection, Hong Kong, China, 2018, and other HEV genotypes. The bootstrap analysis was performed with 1,000 replicates. Bootstrap values <70% are not shown. The analysis included 382 nt positions. GenBank accession numbers are shown in parentheses. Asterisks (*) indicate locally identified cases of HEV infection; arrows (←) indicate HEV outbreak cases from this study. Scale bar indicates estimated number of substitutions per site. HEV, hepatitis E virus.
Main Article
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.